Cargando…

Characterization of chromatin regulators identified prognosis and heterogeneity in hepatocellular carcinoma

Liver carcinogenesis is a multiprocess that involves complicated interactions between genetics, epigenetics, and transcriptomic alterations. Aberrant chromatin regulator (CR) expressions, which are vital regulatory epigenetics, have been found to be associated with multiple biological processes. Nev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dai, Yin-wei, Chen, Han-bin, Pan, Ya-ting, Lv, Lin-xi, Wang, Wei-ming, Chen, Xiao-Hu, Zhou, Xiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505021/ https://www.ncbi.nlm.nih.gov/pubmed/36158697 http://dx.doi.org/10.3389/fonc.2022.1002781

Ejemplares similares

Analysis of risk factors of hepatocellular carcinoma and establishment of a clinical prognosis model
por: Ge, Xin-Yu, et al.
Publicado: (2023)

Tumor Immune Microenvironment Characterization in Hepatocellular Carcinoma Identifies Four Prognostic and Immunotherapeutically Relevant Subclasses
por: Gao, Xingxing, et al.
Publicado: (2021)

Transcriptomic Analysis Identified Two Subtypes of Brain Tumor Characterized by Distinct Immune Infiltration and Prognosis
por: Shen, Xilin, et al.
Publicado: (2021)

Single-Cell Profiling of Tumor Microenvironment Heterogeneity in Osteosarcoma Identifies a Highly Invasive Subcluster for Predicting Prognosis
por: Guo, Junfeng, et al.
Publicado: (2022)

Characterization of the Estrogen Response Helps to Predict Prognosis and Identify Potential Therapeutic Targets in Cholangiocarcinoma
por: Lu, Chenglin, et al.
Publicado: (2022)

An anoikis-related gene signature predicts prognosis and reveals immune infiltration in hepatocellular carcinoma
por: Chen, Yang, et al.
Publicado: (2023)

Prognosis of Extracapsular Spread of Cervical Lymph Node Metastases in Nasopharyngeal Carcinoma
por: Yin, Xue, et al.
Publicado: (2020)

An Immune-Related Gene Pairs Signature Predicts Prognosis and Immune Heterogeneity in Glioblastoma
por: Zhang, Nijia, et al.
Publicado: (2021)

Comprehensive Analysis Identified Mutation-Gene Signature Impacts the Prognosis Through Immune Function in Hepatocellular Carcinoma
por: Lin, Zhuo, et al.
Publicado: (2022)

Radiomics-based nomogram as predictive model for prognosis of hepatocellular carcinoma with portal vein tumor thrombosis receiving radiotherapy
por: Huang, Yu-Ming, et al.
Publicado: (2022)

Comprehensive Characterization of Immune Landscape Based on Epithelial-Mesenchymal Transition Signature in OSCC: Implication for Prognosis and Immunotherapy
por: Zhang, Si-yuan, et al.
Publicado: (2021)

The Presence of Circulating Tumor Cell Cluster Characterizes an Aggressive Hepatocellular Carcinoma Subtype
por: Yu, Jing-Jing, et al.
Publicado: (2021)

Identification and Characterization of Genes Related to the Prognosis of Hepatocellular Carcinoma Based on Single-Cell Sequencing
por: Chen, Wenbiao, et al.
Publicado: (2022)

Simple Clinical Metrics Enhance AFP to Effectively Identify Cirrhotic Patients With Complicating Hepatocellular Carcinoma at Various AFP Levels
por: Zhang, Xi, et al.
Publicado: (2020)

The expression of cuproptosis-related genes in hepatocellular carcinoma and their relationships with prognosis
por: Zhao, Xueying, et al.
Publicado: (2022)

Personalized quantitative models of NAD metabolism in hepatocellular carcinoma identify a subgroup with poor prognosis
por: Chedere, Adithya, et al.
Publicado: (2022)

Characterization of lipid droplet metabolism patterns identified prognosis and tumor microenvironment infiltration in gastric cancer
por: Liu, Mengxiao, et al.
Publicado: (2023)

Comprehensive characterization of ferroptosis in hepatocellular carcinoma revealing the association with prognosis and tumor immune microenvironment
por: Zhu, Jingjuan, et al.
Publicado: (2023)

Novel Potential Biomarkers Associated With Epithelial to Mesenchymal Transition and Bladder Cancer Prognosis Identified by Integrated Bioinformatic Analysis
por: Wang, Chengyuan, et al.
Publicado: (2020)

Genetic testing and prognosis of sarcomatoid hepatocellular carcinoma patients
por: Jia, Bin, et al.
Publicado: (2023)

Identifying and Validating Potential Biomarkers of Early Stage Lung Adenocarcinoma Diagnosis and Prognosis
por: Chen, Yingji, et al.
Publicado: (2021)

Impact of metabolic syndrome on the long-term prognosis of patients with hepatitis B virus-related hepatocellular carcinoma after hepatectomy
por: Zhang, Kang-Jun, et al.
Publicado: (2022)

A Novel Multimodal Radiomics Model for Predicting Prognosis of Resected Hepatocellular Carcinoma
por: He, Ying, et al.
Publicado: (2022)

Pyroptosis-Related LncRNA Signature Predicts Prognosis and Is Associated With Immune Infiltration in Hepatocellular Carcinoma
por: Liu, Ze-Kun, et al.
Publicado: (2022)

Unraveling tumor microenvironment heterogeneity in malignant pleural mesothelioma identifies biologically distinct immune subtypes enabling prognosis determination
por: Yang, Kaidi, et al.
Publicado: (2022)

Tumor burden score dictates prognosis of patients with combined hepatocellular cholangiocarcinoma undergoing hepatectomy
por: Deng, Gang, et al.
Publicado: (2023)

Over-expression of RRM2 predicts adverse prognosis correlated with immune infiltrates: A potential biomarker for hepatocellular carcinoma
por: Qin, Zhongqiang, et al.
Publicado: (2023)

Circulating immune index predicting the prognosis of patients with hepatocellular carcinoma treated with lenvatinib and immunotherapy
por: Guo, De-Zhen, et al.
Publicado: (2023)

Case report: A case of heterogeneity of the antitumor response to immune checkpoint inhibitors in a patient with relapsed hepatocellular carcinoma
por: Bao, Yingying, et al.
Publicado: (2022)

Characterization of Tumor Microenvironment in Lung Adenocarcinoma Identifies Immune Signatures to Predict Clinical Outcomes and Therapeutic Responses
por: Chen, Donglai, et al.
Publicado: (2021)

Corona enhancement combined with microvascular invasion for prognosis prediction of macrotrabecular-massive hepatocellular carcinoma subtype
por: Yang, Lili, et al.
Publicado: (2023)

Four circadian rhythm-related genes predict incidence and prognosis in hepatocellular carcinoma
por: Wu, Zhenyu, et al.
Publicado: (2022)

Tissue metabolomics identified new biomarkers for the diagnosis and prognosis prediction of pancreatic cancer
por: Liu, Chang, et al.
Publicado: (2022)

Identification METTL18 as a Potential Prognosis Biomarker and Associated With Immune Infiltrates in Hepatocellular Carcinoma
por: Li, Tian-Hao, et al.
Publicado: (2021)

Single-Cell Transcriptome Analysis Identifies Ligand–Receptor Pairs Associated With BCP-ALL Prognosis
por: Wu, Liang, et al.
Publicado: (2021)

High Levels of DEAH-Box Helicases Relate to Poor Prognosis and Reduction of DHX9 Improves Radiosensitivity of Hepatocellular Carcinoma
por: Chen, Xi, et al.
Publicado: (2022)

Identification of PAFAH1B3 as Candidate Prognosis Marker and Potential Therapeutic Target for Hepatocellular Carcinoma
por: Xu, Weikang, et al.
Publicado: (2021)

Scutellaria barbata Inhibits Hepatocellular Carcinoma Tumorigenicity by Inducing Ferroptosis of Hepatocellular Carcinoma Cells
por: Li, Yue, et al.
Publicado: (2022)

A macropinocytosis-related gene signature predicts the prognosis and immune microenvironment in hepatocellular carcinoma
por: Ding, Xinjiang, et al.
Publicado: (2023)

CpG Site-Specific Methylation-Modulated Divergent Expression of PRSS3 Transcript Variants Facilitates Nongenetic Intratumor Heterogeneity in Human Hepatocellular Carcinoma
por: Lin, Shuye, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vteot9q207n7su5q3heai7sesn